Then how to you account for the many fines that have been imposed on pharmaceutical companies for exactly this kind of misrepresentation?All drugs have adverse effects, some worse than others. Taking drugs is about balancing the risks - the perpetual battle of efficacy versus safety.
Clinical study phases are designed around safety, tolerability, efficacy, combination therapy (I.e combinations of drugs) and dose scheduling. Each of these phases can have dozens of individual studies that investigate all kinds of different cohorts; age, sex, race, fitness, medical history, alcohol consumption etc. They are very comprehensive, which is part of the reason why it takes 10 years of studying a drug before it comes to market.
Will some adverse effects be discovered when the drug has come to market? Possibly. Are there any malicious people at pharma companies knowingly putting patient safety at risk for the sake of pleasing the shareholders? Definitely not.
In addition, many people that take drugs for chronic conditions tend to be unwell, or prone to illness. It's very difficult, in a non-clinical setting, to isolate an adverse effect of a drug, to an adverse effect from a chronic condition or lifestyle factors.
Because as I said it's not usually misrepresentation. People often assume because safety trials haven't been disclosed, that it's some sort of malicious act, when there's all kinds of reasons why a trial is not used. If an experiment is flawed, it's best not to include it.Then how to you account for the many fines that have been imposed on pharmaceutical companies for exactly this kind of misrepresentation?
It seems to me there's a grey area that shades from "this medicine definitely saves lives, so the side effects are tolerable, and it brings in a profit, so it's worth manufacturing" through "this medicine is likely on balance to help, so the side effects are tolerable" and ends with "this medicine does no known harm and it makes a profit, and the side effects are tolerable, so it's worth manufacturing". None of these is illegal and none puts patient safety at risk, so although only the first could really be called "health comes first", it's hard for an outsider to know which one is the motivator for which medicine.Doesn't sound like 'health comes first' to me.
Absolutely, pharma companies are shareholder and profit-driven. Personally I think they're too shareholder driven. I too also disagree with underhand tactics such as doctor bribery etc.
My point isn't about that. It's that, it's that drug trials run by pharma companies are extremely safety and regulatory driven. There will always be exceptions when something hits the headlines, but even in those cases, there was likely to be a reasonable answer as to why safety statistics weren't reported.
Sanguine, I do believe that CoQ10 is prescribed to people who suffer from statin-induced muscle aches. If you don't suffer from the symptoms of CoQ10 deficiency, then chances are, you don't have the deficiency, or it is tolerable. I wouldn't want to take drugs I don't need. Taking CoQ10 can cause stomach upsets, loss of appetite, nausea, diarrhea, skin rashes and low blood pressure. So, there probably were safety considerations when deciding to not include it with the statin.
I think the instructions that come with statins report that users may suffer from muscle aches, which is the symptom of CoQ10 deficiency. I'm sure they state that you should go to your doctor if you suffer this. I think this is sounds advice.
Not me, even though I have a genetic Q10 deficiency even without any help from statins. What happened was that the db consultant said looking at at my age and weight at diagnosis, my pattern of high fasting bg but normal OGTT results, the very slow progress of my db and my history of stroke at a young age without risk factors, he suspected MIDD or MELAS. He gave me some articles to read about them, and this was shortly after I'd had intolerable side effects from simvastatin. In the literature it mentioned Q10 deficiency as a common symptom of these db syndromes and said statin use was contraindicated, so at the next appt I raised it my statin problem with him, he got me tested, and bingo! Q10 deficiency was diagnosed!Coq10 was never, ever discussed with me, ever... I bought my own after researching the internet... Certainly never prescribed. I hope that someone comes forward and differs with the advice I was given.
Thanks, I think!Sam, I applaud you for putting your point of view into what is an interesting discussion, you must feel you are in a small minority flying the flag for the pharm companies against an army of total cynics! Anyway,
A great deal of effort goes into competitor intelligence; I myself have worked in this area. Competitor intelligence can save (or cost, depending on which end of it you're on) a lot of time and money. For example, I work in oncology and I recently wanted to find what chemo drug in combination with a competitor's drug (which was similar to ours), produced the most adverse events. Combination trials are costly and difficult to do because you have more than one variable drug.Ah, but you understand our point that it's not the safety and regulatory aspects of the trials per se that's the issue (well it is a bit), but the availability of the data in those trials to entities that can carry out a truly independent review and audit of them. You say commercial confidentiality is an issue here, but again I would assume that all major pharm companies are doing very similar things and can certainly analyse each others' products, so what exactly is at stake, especially in the case of assessment of side effects?
Of course, if all the companies pooled their trial data and saved all that money for the common good - no, stupid idea, why would that work ...
But as Indy has pointed out (elsewhere if not here, maybe in the statins side-effects poll thread http://www.diabetes.co.uk/forum/threads/poll-side-effects-from-statins.58409/ CoQ10 is a natural product - are you saying the natural CoQ10 that the statins inhibit also has these effects? I think I'd sooner have the 'real' one left intact thanks (the pharm companies are desperately trying to find something that focusses on cholesterol further down the biochemical evolution tree to avoid CoQ10 and dolichol inhibition, so what does that tell us?).
Well it does, once you get past the screaming 'don't take with grapefruit' bit. But how disingenuous is it not to mention CoQ10 in that respect if that is 'the symptom'? You can get muscle aches for all sorts of reasons, I haven't seen anyone on the statin poll thread say they've been to the GP complaining about muscle pain, and the GP says 'Oh that must be due to CoQ10 inhibition'. It usually seems to be more like 'well what do you expect at your age?. If the patient even realises the connection AND bothers to report it at all, AND if the GP then relays that back to NICE.
Don't worry, I'm not taking anything personally! I don't want to give the impression that I think pharma companies are whiter than white. They're not, there's bad eggs working in every industry and no-doubt some of them are making bad decisions at pharma companies.I'm not a Samjb basher, and I do fully understand (don't agree) with his thoughts, it is interesting to hear some thoughts from people within these industries like Sam.
Thnx Sam for your insight to how you perceive drug companies, it is very enlightening...
Sent from the Diabetes Forum App
Not me, even though I have a genetic Q10 deficiency even without any help from statins. What happened was that the db consultant said looking at at my age and weight at diagnosis, my pattern of high fasting bg but normal OGTT results, the very slow progress of my db and my history of stroke at a young age without risk factors, he suspected MIDD or MELAS. He gave me some articles to read about them, and this was shortly after I'd had intolerable side effects from simvastatin. In the literature it mentioned Q10 deficiency as a common symptom of these db syndromes and said statin use was contraindicated, so at the next appt I raised it my statin problem with him, he got me tested, and bingo! Q10 deficiency was diagnosed!
My point is that even when a specialist suspected I had a condition that commonly includes Q10 deficiency, he didn't connect it with statins or think to warn me. To be fair the simva had been prescribed by my GP on his own initiative, not in consultation with the specialist. Even when I went back to the GP before seeing the consultant and told him about the side effects he didn't mention Q10.
So this reinforces your point that it's rare for HCPs to make any connection between Q10 and statin use. When I mentioned it to another GP in the group practice he treated me as if I were a batty old dear extolling the virtues of homeopathic oil of evening primrose and said he was sure taking supplements wasn't likely to do me any harm if it made me feel happy. Grr.
Kate
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?